v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 1,340,251 $ 1,007,346
Adjustments to reconcile net income to cash (used in) provided by operating activities:    
Depreciation and amortization 443,266 380,529
Share-based compensation 22,904 16,713
Deferred income taxes (37,466) 26,477
Other, net 43,196 36,274
Changes in operating assets and liabilities:    
Accounts receivable, trade (290,973) (196,967)
Inventories (348,993) (679)
Government grants receivable (1,285,786) (442,010)
Other assets 15,328 (150,159)
Income tax receivable and payable 56,711 (44,684)
Accounts payable and accrued expenses (147,210) (164,194)
Deferred revenue (220,745) 262,877
Other liabilities 6,803 83,689
Net cash (used in) provided by operating activities (402,714) 815,212
Cash flows from investing activities:    
Purchases of property, plant and equipment (434,662) (698,148)
Purchases of marketable securities and restricted marketable securities (1,824,044) (1,307,656)
Proceeds from sales and maturities of marketable securities 1,824,833 1,424,918
Other investing activities 5,806 2,952
Net cash used in investing activities (428,067) (577,934)
Cash flows from financing activities:    
Proceeds from borrowings under debt arrangements, net of issuance costs 339,960 309,047
Repayment of debt (732,121) (357,515)
Proceeds from other borrowings 0 487,323
Repayment of other borrowings 0 (298,407)
Payments of tax withholdings for restricted shares (945) (15,479)
Other financing activities (874) (527)
Net cash (used in) provided by financing activities (393,980) 124,442
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents 3,670 2,021
Net (decrease) increase in cash, cash equivalents, restricted cash, and restricted cash equivalents (1,221,091) 363,741
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of the period 2,814,031 1,638,223
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of the period 1,592,940 2,001,964
Supplemental disclosure of noncash investing and financing activities:    
Property, plant and equipment acquisitions funded by liabilities 128,461 222,115
Proceeds to be received from asset-based government grants $ 111,681 $ 149,775